Search

everythinglearnresearchcommunity

for

Search:↓

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Damage to hair follicle stem cells may cause permanent hair loss and scarring in PCA.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Oxidative stress contributes to hair graying and loss as we age.

Two teenage brothers had a rare, treatment-resistant form of female-pattern hair loss with unusual scalp changes.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

Hair loss in women, often not related to male hormones, increases with age and can cause significant emotional distress.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Complex therapy is more effective for long-term control of scalp abscesses.

Horizontal scalp biopsy sections effectively diagnose and predict MPAA, with follicular density and inflammation impacting hair regrowth.

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.

Early treatment of acne is crucial to prevent scarring and psychological effects.

Lichen planus pigmentosus and fibrosing frontal alopecia in Colombia are likely different stages of the same disease.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

Hair loss in systemic lupus erythematosus patients is unique and improves with treatment.

Alternative treatments show promise for hair growth beyond traditional methods.

Adjuvants, diet changes, and laser therapy may improve male pattern hair loss.

LLLT helps treat hair loss by increasing blood flow, reducing inflammation, and stimulating growth factors.

All skin diseases might start in hair follicles.

Hair ages and thins due to factors like inflammation and stress, and treatments like antioxidants and hormones might improve hair health.

COVID-19 can cause significant hair loss.

Cyclosporine improved skin condition in dogs with sebaceous adenitis.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

The document concludes that fexofenadine reduces inflammation in chronic hives, cholestyramine helps half of pregnant women with itchy rashes, and relaxing incisions are a good alternative in facial surgery for the elderly.

The document suggests that severe hair loss in SLE patients may be an early sign of scalp DLE, treatable with immunosuppressive therapy.

People with late-stage HIV-1 often experience a specific type of hair loss linked to multiple factors, including nutritional issues and immune responses.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Platelet-rich plasma (PRP) may help treat hair loss in patients with frontal fibrosing alopecia who don't respond to other treatments.

New treatments for hair loss show promise, but more development is needed, especially for tough cases.